针对有脊柱手术史的脊髓损伤后神经病理性疼痛患者,在适当部位放置桨型电极行差异化靶向多路脊髓电刺激:探索性临床试验的研究方案
本研究为单中心、开放标签、随机、双向交叉探索性临床试验,针对有脊柱手术史的脊髓损伤后神经病理性疼痛患者,在适当部位放置桨型电极行差异化靶向多路(DTM)脊髓电刺激(SCS),主要结局为SCS系统植入后3个月疼痛改善率(疼痛缓解超过33%)。
要点
- 研究分两步:SCS试验(第一步)和SCS系统植入(第二步)。
- 主要结局为SCS系统植入后3个月疼痛缓解超过33%的改善率。
- DTM刺激联合桨型电极置于SCI头侧可能为顽固性疼痛提供显著缓解。
核心结论
- 将桨型电极放置在SCI头侧并使用DTM刺激可能为有脊柱手术史的SCI后顽固性神经病理性疼痛患者提供显著疼痛缓解。
研究设计与样本
- 单中心、开放标签、随机、双向交叉探索性临床试验,纳入有脊柱手术史的脊髓损伤后神经病理性疼痛患者。
- 研究分两步:SCS试验(第一步)和SCS系统植入(第二步)。
主要发现
- 主要结局为SCS系统植入后3个月疼痛缓解超过33%的改善率。
- 次要结局包括:SCS试验期间DTM与常规 tonic 刺激的有效性;1至24个月评估指标的变化;SCS试验结果与SCS系统植入后3个月效果的关系;与长期效果(持续超过12个月)相关的术前因素;以及1至24个月步态功能是否改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neuropathic pain after spinal cord injury (SCI), both traumatic and non-traumatic, is refractory to various treatments. Spinal cord stimulation (SCS) is one of the neuromodulation therapies for neuropathic pain, although SCS has insufficient efficacy for neuropathic pain after SCI. The reasons are presumed to be inappropriate locations of SCS leads and conventional tonic stimulation itself does not have a sufficient analgesic effect for the pain. In patients with past spinal surgical histories, the cylinder-type leads are likely to be placed on the caudal side of the SCI because of surgical adhesions. Differential target multiplexed (DTM) stimulation is one of the latest new stimulation patterns that is superior to conventional stimulation. METHODS: A single-center, open-label, randomized, two-way crossover trial is planned to investigate the efficacy of SCS using DTM stimulation placing a paddle lead at the appropriate site for neuropathic pain after SCI in patients with spinal surgical histories. The paddle-type lead delivers energy more efficiently than a cylinder-type lead. This study consists of two steps: SCS trial (first step) and SCS system implantation (second step). The primary outcome is rates of achieving pain improvement with more than 33% reduction 3 months after SCS system implantation. The secondary outcomes are to be evaluated as follows: (1) effectiveness of DTM and tonic stimulations during the SCS trial; (2) changes of assessment items from 1 to 24 months; (3) relationships between the result of the SCS trial and the effects 3 months after SCS system implantation; (4) preoperative factors associated with a long-term effect, defined as continuing for more than 12 months; and (5) whether gait function improves from 1 to 24 months. DISCUSSION: A paddle-type lead placed on the rostral side of SCI and using DTM stimulation may provide significant pain relief for patients with intractable neuropathic pain after SCI in patients with past spinal surgical histories. TRIAL REGISTRATION: Japan Registry of Clinical Trials (jRCT) jRCT 1042220093. Registered on 21 November 2022, and last modified on 6 January 2023. jRCT is approved as a member of the Primary Registry Network of WHO ICTRP.
引用
- Tanei T, Maesawa S, Nishimura Y, et al. Differential target multiplexed spinal cord stimulation using a paddle-type lead placed at the appropriate site for neuropathic pain after spinal cord injury in patients with past spinal surgical histories: study protocol for an exploratory clinical trial. Trials. 2023. PMID: 37308986. doi:10.1186/s13063-023-07433-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。